✓ Credit card payment restored — secure checkout via Privacy Shield

Depin

Depin is nifedipine 5 / 10 mg capsules from Cadila — first-generation dihydropyridine CCB. Lower doses used for Raynaud’s, chilblains, and vasospastic conditions. For chronic hypertension, use the extended-release formulations (Nicardia Retard, Cardipin Retard) rather than IR capsules. Pregnancy-safe; also used for tocolysis (preterm labour).

Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience  · Last reviewed: May 2026

Buy more, save more Price per tablet
Select a strength above to see pack pricing.
Encrypted checkout
Crypto pays 10% less
Discreet worldwide delivery
1,400+ customers · 50+ countries

⚡ Quick Answer — What is Depin?

Depin is a 5 / 10 mg nifedipine tablet from Cadila Pharmaceuticals — a first-generation dihydropyridine calcium-channel blocker (CCB). Introduced 1981 (Bayer as Adalat / Procardia) — the original dihydropyridine CCB. Short-acting immediate-release nifedipine caused controversy in the 1990s after reports of MI and mortality increase with sublingual / rapid-onset formulations; modern practice uses extended-release (Retard, MR, CC, XL, OROS) formulations exclusively for chronic hypertension. Plasma half-life IR ~2-5 hours; Retard / MR / CC / XL ~20-24 hours. Use ONLY extended-release nifedipine (Retard, MR, CC, XL, OROS, GITS) for chronic hypertension. Sublingual or crushed immediate-release nifedipine is contraindicated for chronic BP control — it causes rapid BP drops with reflex sympathetic activation, tachycardia, and in some studies MI or mortality. The ER formulations avoid these problems by delivering a smooth 24-hour plasma profile. Typical hypertension dose: Retard 20 mg twice daily OR CC/XL 30 mg once daily; target Retard 20-30 mg twice daily OR CC/XL 30-60 mg once daily. Main side effects: ankle (peripheral) oedema, flushing, headache from vasodilation, reflex tachycardia (blunted by amlodipine’s long half-life; common with IR nifedipine). Safe to combine with beta-blockers, ACE inhibitors, ARBs, and thiazides (unlike non-DHP CCBs). Pregnancy: nifedipine MR is pregnancy-safe and often first-line; amlodipine is reasonable second option.

What you get with MedsBase: WHO-GMP certified manufacturer · Discreet packaging · Worldwide shipping · 1,400+ verified customer reviews

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

Why order from MedsBase

Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.

What Is Depin?

Depin is an oral 5 / 10 mg nifedipine tablet from Cadila Pharmaceuticals, supplied in 30-180 capsules. Introduced 1981 (Bayer as Adalat / Procardia) — the original dihydropyridine CCB. Short-acting immediate-release nifedipine caused controversy in the 1990s after reports of MI and mortality increase with sublingual / rapid-onset formulations; modern practice uses extended-release (Retard, MR, CC, XL, OROS) formulations exclusively for chronic hypertension.

Nifedipine belongs to the dihydropyridine calcium-channel blocker subclass, distinguished from the non-dihydropyridines (diltiazem, verapamil) by its selective action on vascular smooth muscle with minimal direct cardiac effect. This selectivity profile is clinically important: DHPs can be combined safely with beta-blockers (the combination is standard in angina), while non-DHPs cannot (additive bradycardia/heart-block risk).

How Nifedipine Works

Calcium-channel blockers bind L-type voltage-gated calcium channels and reduce calcium influx into the cell during depolarisation. In arterial smooth muscle, reduced calcium entry means less actin-myosin interaction and direct arterial vasodilation — lowering systemic vascular resistance and blood pressure.

Dihydropyridines are ~10-fold more potent on vascular smooth muscle than on cardiac muscle — so the dominant clinical effect is vasodilation, with minimal direct suppression of cardiac contractility or conduction. The body’s baroreflex can trigger mild reflex tachycardia after fast-onset vasodilation; this is the problem with short-acting nifedipine that led to the 1990s controversy — modern ER formulations eliminate it via slow smooth onset.

Onset of clinical effect: Retard onset 1-4 hours; full BP effect at 1-2 weeks.

Approved and Evidence-Based Uses

  • Hypertension — Retard / CC / XL formulation only
  • Hypertension in pregnancy — Retard/MR is first- or second-line alongside labetalol and methyldopa
  • Preterm labour tocolysis (off-label but widely used) — relaxes uterine smooth muscle
  • Prinzmetal / vasospastic angina
  • Raynaud’s phenomenon
  • Chronic stable angina — often combined with a beta-blocker (the beta-blocker blunts the reflex tachycardia)

Pivotal trial evidence: INSIGHT (2000) — nifedipine GITS non-inferior to co-amilozide for CV events in HTN. ACTION (2004) — nifedipine GITS added to standard angina therapy reduced need for coronary procedures.

Depin Dosage

Hypertension:

  • Starting dose: Retard 20 mg twice daily OR CC/XL 30 mg once daily
  • Target dose: Retard 20-30 mg twice daily OR CC/XL 30-60 mg once daily
  • Maximum: Retard 60 mg twice daily OR CC/XL 90 mg once daily
  • Titrate every 1-2 weeks based on BP response and tolerability (particularly oedema)

Angina: Retard 20-40 mg twice daily

Administration: once daily (or twice daily for IR nifedipine formulations). Swallow whole — do NOT crush or split extended-release formulations (delivers an IR dose with risk of hypotension). Take with or without food.

Discontinuation: no specific withdrawal syndrome; can be stopped without taper. BP will return to pre-treatment levels within 1-2 weeks.

Side Effects

Common (>5%, mostly mild and transient):

  • Peripheral (ankle) oedema — Peripheral (ankle) oedema — similar mechanism to amlodipine; more common with nifedipine at higher doses. Gum hyperplasia is a recognised long-term complication (10-15% after 2+ years); practice meticulous oral hygiene and schedule dental reviews.
  • Flushing (warm face and upper body)
  • Headache (particularly at start of therapy; usually adapts within 2-4 weeks)
  • Reflex tachycardia (palpitations) — less common with long-acting formulations
  • Dizziness, postural hypotension
  • Fatigue
  • Mild constipation (less than non-DHPs)

Uncommon:

  • Gingival hyperplasia (gum overgrowth) — 10-15% of long-term users; practice meticulous oral hygiene and schedule dental reviews every 6 months
  • Rash, pruritus
  • Nausea, abdominal discomfort
  • Erectile dysfunction (rare)
  • Liver enzyme elevations (usually mild, reversible)
  • Rare reports of photosensitivity

Historical warning: short-acting (immediate-release) nifedipine capsules, particularly when used sublingually for “hypertensive urgency”, were associated with myocardial infarction and mortality increase in the 1990s (Psaty 1995). Modern practice uses ER (Retard/MR/CC/XL/OROS) formulations exclusively for chronic HTN. Never crush or open an ER capsule to make an IR dose.

Contraindications & Cautions

  • Known hypersensitivity to nifedipine or dihydropyridine class
  • Cardiogenic shock
  • Severe aortic stenosis (can cause critical hypotension)
  • Unstable angina or MI within 1 month (DHPs other than amlodipine)
  • Obstructive hypertrophic cardiomyopathy (reduces outflow gradient dynamically)
  • Severe hepatic impairment (all DHPs are hepatically metabolised)

Pregnancy: nifedipine MR is pregnancy-safe and is first- or second-line for gestational hypertension and preeclampsia alongside labetalol and methyldopa. Also used off-label for preterm-labour tocolysis.

Breastfeeding: small amounts in breast milk; generally considered acceptable with infant monitoring.

Drug Interactions

  • Grapefruit juice — inhibits CYP3A4 metabolism; can raise plasma levels of amlodipine and particularly nifedipine/nimodipine by 2-3×. Avoid on treatment days, or use consistently if at all.
  • Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, ritonavir, cobicistat) — raise CCB plasma levels; reduce dose or avoid
  • Strong CYP3A4 inducers (rifampicin, phenytoin, carbamazepine, St John’s wort) — reduce CCB plasma levels; may need dose increase
  • Simvastatin — amlodipine modestly increases simvastatin exposure; cap simvastatin at 20 mg/day when combined
  • Beta-blockers — DHPs combine safely with beta-blockers (the combination is standard in angina — beta-blocker blunts reflex tachycardia, CCB provides vasodilation). Distinct from non-DHP CCBs (diltiazem, verapamil) which should NOT be combined with beta-blockers.
  • Other antihypertensives — generally complementary; monitor BP
  • Sildenafil / tadalafil (PDE5 inhibitors for erectile dysfunction) — additive hypotension; caution particularly at high CCB doses

Calcium-Channel Blocker Class at a Glance

CCBClassNiche
Amlodipine (Amlode, Amlip)DHP (3rd gen)Reference DHP; once-daily HTN + angina; ASCOT evidence
Nifedipine (Depin, Nicardia Retard, Cardipin)DHP (1st gen)Pregnancy-safe MR; tocolysis; must use ER formulations for chronic HTN
Nimodipine (Nimodip)DHP (cerebrovascular)Subarachnoid haemorrhage vasospasm prevention — NOT for routine HTN
Diltiazem (Dilzem, Dilzem CD)Non-DHP (benzothiazepine)HTN + rate control + angina; moderate cardiac effect
Verapamil (Calaptin 40, Calaptin SR)Non-DHP (phenylalkylamine)Strongest cardiac effect; SVT, AF rate, cluster headache

DHP vs non-DHP — why it matters: DHPs (amlodipine, nifedipine) act selectively on arterial smooth muscle with minimal cardiac effect — safe to combine with beta-blockers. Non-DHPs (diltiazem, verapamil) slow AV nodal conduction and reduce cardiac contractility — do NOT combine with beta-blockers (additive bradycardia, heart block, acute heart failure risk). If your patient is already on a beta-blocker, use a DHP.

Storage

Store Depin below 25°C. Protect from light. Keep out of reach of children.

Frequently Asked Questions

Why have my ankles started swelling after Depin?

Peripheral oedema is a class effect of dihydropyridines, caused by pre-capillary arteriolar dilation that raises hydrostatic pressure in the lower-leg venules. It is NOT fluid overload and does NOT respond to diuretics. Management options: (1) reduce the CCB dose; (2) add an ACE inhibitor or ARB which balances pre- and post-capillary vasodilation and eliminates the oedema mechanism (often the preferred solution); (3) switch to a non-DHP CCB (diltiazem, verapamil) if rate-related side effects are acceptable; (4) leg elevation and compression stockings as adjuncts.

How long does Depin take to lower blood pressure?

ER/Retard nifedipine: noticeable BP drop within 1-4 hours; full effect at 1-2 weeks.

Can I take Depin with a beta-blocker?

Yes — DHPs combine safely with beta-blockers. The combination is standard in angina: the DHP vasodilates and reduces myocardial oxygen demand; the beta-blocker blunts the reflex tachycardia. This is different from non-DHP CCBs (diltiazem, verapamil) which should NOT be combined with beta-blockers due to additive bradycardia and heart-block risk.

Can I eat grapefruit on Depin?

Grapefruit (juice and fresh fruit) inhibits CYP3A4 metabolism and can raise nifedipine plasma levels by 2-3×, increasing the risk of hypotension, dizziness, and oedema. Best practice: avoid grapefruit/juice while on CCBs, or consume consistently (your dose is titrated to BP response; sporadic grapefruit disrupts that).

Is Depin safe in pregnancy?

Nifedipine MR is pregnancy-safe and is first- or second-line antihypertensive in pregnancy alongside labetalol and methyldopa. Also used off-label to delay preterm labour (tocolysis).

Can I combine Depin with my other BP medications?

Yes — DHP CCBs combine well with ACE inhibitors (ramipril, lisinopril), ARBs (losartan, telmisartan, olmesartan), beta-blockers (bisoprolol, metoprolol), and thiazide diuretics (HCTZ). The ACEi/ARB + CCB combination is particularly useful because it eliminates the ankle oedema side effect.

Why should I not use immediate-release nifedipine for chronic HTN?

Short-acting (immediate-release) nifedipine causes rapid BP drops with reflex sympathetic activation — tachycardia and a surge in sympathetic tone that, in some observational studies from the 1990s, was associated with myocardial infarction and mortality increase. The extended-release formulations (Retard, MR, CC, XL, OROS) deliver the same total daily dose over 24 hours with a smooth plasma profile and do not have this problem. Always use extended-release nifedipine for chronic hypertension, never IR capsules.

Where can I buy Depin online?

You can buy Depin (nifedipine 5 / 10 mg, 30-180 capsules) from MedsBase with discreet packaging and worldwide shipping.

Related Antihypertensives on MedsBase

⚕ Medical Disclaimer. This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Hypertension, heart failure, and arrhythmias require diagnosis, monitoring, and dose individualisation by a doctor — always use beta-blockers under medical guidance.

Related Alternatives

Other products in Chronic Conditions that customers also view:

More options in High Blood Pressure Medication

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Strength

5 mg, 10 mg

Quantity

30 Tablet/s, 60 Tablet/s, 90 Tablet/s

Pharma Form

Capsule/s

Manufacturer

Zydus Cadila Pharma

Treatment

High blood pressure, Chest pain (Angina)

Generic Brand

Nifedipine

Reviews

There are no reviews yet

Add a review
Depin Depin
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review

Q & A

Ask a question
Depin Depin
Your question
* Question is required
Name
* Name is required
There are no questions yet